Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04043169 · ClinicalTrials.gov registry record

Clearblue Pregnancy Test - Lay User Study

A clinical trial of Pregnancy, sponsored by SPD Development Company Limited.

Completed
Registry status
204
Enrollment target
1
Study location

NCT04043169 is a study of Pregnancy that has completed, run by SPD Development Company Limited. The registered enrollment target is 204 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04043169, a study of Pregnancy, has completed, sponsored by SPD Development Company Limited.

COMPLETED
Registry status
204 participants
Enrollment target
1
Study location

Study Summary

The Clearblue home pregnancy test (HPT) is an over-the-counter urine hCG (human chorionic gonadotropin) integrated digital test which is intended for the detection of pregnancy. This study will assess the performance of a HPT in the hands of lay-users by comparing their results when used according to the instructions for use (IFU) to (i) confirmed pregnancy status of the volunteers and (ii) to the results of trained study staff testing the same urine samples.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Clearblue pregnancy test

Study Locations (1)

California

  • WCCT - Cypress

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2019-07-30
Est. Completion 2019-12-31

Sponsor

SPD Development Company Limited

3 total trials

What the Registry Record Tells You About NCT04043169

The ClinicalTrials.gov registry entry for NCT04043169 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (77% lower). The listed sponsor is SPD Development Company Limited, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Clearblue pregnancy test is the first listed.

NCT04043169 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04043169 about?

NCT04043169 is a clinical study titled "Clearblue Pregnancy Test - Lay User Study". The Clearblue home pregnancy test (HPT) is an over-the-counter urine hCG (human chorionic gonadotropin) integrated digital test which is intended for the detection of pregnancy. This study will assess the performance of a HPT in the hands of lay-users by comparing their results when used according t...

What is the current status of trial NCT04043169?

This trial is currently completed. The enrollment target is 204 participants. The study started on 2019-07-30. Estimated completion is 2019-12-31.

What conditions does trial NCT04043169 study?

This clinical trial studies the following conditions: Pregnancy.

What interventions are being tested in trial NCT04043169?

The interventions under investigation include: Clearblue pregnancy test (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04043169?

This trial is sponsored by SPD Development Company Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04043169 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.